Cardiomyopathy induced by cardiac Gs alpha overexpression

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Animal Models of Disease

Background:

• The role of sympathetic nervous system overactivity in heart disease is a significant area of research.
• Understanding the molecular mechanisms underlying cardiac dysfunction is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate if chronic endogenous sympathetic stimulation, due to Gs alpha overexpression in transgenic mice, results in cardiomyopathy.
• To elucidate the long-term effects of sustained sympathetic activation on cardiac function and survival.

Main Methods:

• Utilized transgenic mice overexpressing cardiac stimulatory G protein alpha subunit (Gs alpha).
• Employed echocardiography to assess left ventricular ejection fraction and dimensions.
• Conducted electrocardiographic monitoring for arrhythmias.
• Compared mortality rates between transgenic and age-matched control mice.

Main Results:

• Older Gs alpha-overexpressing mice showed reduced left ventricular ejection fraction (50.4%) compared to controls (70.9%).
• Gs alpha mice exhibited increased left ventricular end-diastolic dimension and elevated baseline heart rates (722 bpm vs. 656 bpm).
• High incidence of arrhythmias and significantly increased mortality (31.6%) were observed in Gs alpha mice.

Conclusions:

• Chronic sympathetic stimulation from Gs alpha overexpression in mice leads to features of dilated cardiomyopathy.
• Sustained sympathetic activation over an animal's lifetime is deleterious to cardiac health.
• This model supports the concept that prolonged sympathetic overactivity can cause cardiomyopathy.